Much of the NIH-funded research on long COVID has focused on observing and understanding the disease. Some patients and doctors say the research should pivot toward finding new treatments and drugs.
NPR's Michel Martin speaks with American Medical Association President Bruce Scott about how physicians and patients are burdened by insurance companies' systems of prior authorization.
Much of the NIH-funded research on long COVID has focused on observing and understanding the disease. Some patients and doctors say the research should pivot toward finding new treatments and drugs.